3 completed, 2 recruiting, 1 active not recruiting, 1 withdrawn. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Recruiting 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Venous Leg Ulcer: new trials by email Literature Review of Venous Leg Ulcer trials Research Report on Venous Leg Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tissue Repair Gel in Venous Leg Ulcers in AU/US TR987 0.1% gel + Standard of Care, Standard of care - Venous Leg Ulcer, Venous Ulcer | Phase 3 | Recruiting | TR Therapeutics | 312 | 2025-04-01 | 2025-04-02 |
| Tissue Repair Gel in Venous Leg Ulcers (US) TR987 0.1% gel + Standard of Care, Standard of care - Venous Leg Ulcer, Venous Ulcer | Phase 3 | Recruiting | TR Therapeutics | 312 | 2025-01-28 | 2026-02-12 |
| Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) allo-APZ2-CVU, Placebo - Venous Leg Ulcer | Phase 3 | Active not recruiting | RHEACELL GmbH & Co. KG | 250 | 2024-12-26 | 2025-10-01 |
| A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers VitroGro® ECM, Dulbecco's Phosphate Buffered Saline - Venous Leg Ulcer | Phase 2 / Phase 3 | Withdrawn | Tissue Therapies Ltd. | 2017-01-01 | 2017-05-30 | |
| Low Dose Aspirin for Venous Leg Ulcers Aspirin, Placebo - Venous Leg Ulcer | Phase 3 | Completed | University of Auckland, New Zealand | 251 | 2015-03-01 | 2019-01-04 |
| Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers Dermagraft, Profore - Venous Leg Ulcer | Phase 3 | Completed | Shire Regenerative Medicine, Inc. | 225 | 2010-05-01 | 2013-08-21 |
| Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers Dermagraft(R), Profore - Venous Leg Ulcer | Phase 3 | Completed | Organogenesis | 537 | 2009-06-01 | 2018-06-18 |
Varicose Ulcer (7) · Wounds and Injuries (2) · Leg Ulcer (1) · Skin Ulcer (1)
Cardiovascular Diseases (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Varicose Veins (7) · Vascular Diseases (7) · Leg Ulcer (6) · Skin Ulcer (6)
Gels (2) · Standard of Care (2) · Aspirin (1)
TR Therapeutics (2) · Organogenesis (1) · RHEACELL GmbH & Co. KG (1) · Shire Regenerative Medicine, Inc. (1) · Tissue Therapies Ltd. (1) · University of Auckland, New Zealand (1)
United States (5) · Germany (3) · Poland (3) · United Kingdom (3) · Austria (2) · Estonia (2) · South Africa (2) · Sweden (2) · Australia (1) · Czechia (1) · France (1) · Hungary (1) · Italy (1) · Netherlands (1) · Slovakia (1)
Andrew Jull, RN PhD (1) · Anna Moessmer (1) · David Bergqvist, MD (1) · Keith Harding, MD (1) · Mollie Carter, MD (1) · William Marston, MD (1)